Anabolic steroids have medical uses, but an approved use belongs to a specific medicine, patient group and country. Testosterone replacement is one example. A historical use, a research finding and a current product indication are different kinds of evidence and should not be presented as interchangeable.
What a medical indication tells you
An indication describes the condition for which a product is authorised. It does not mean that every drug in the same chemical class has that use. Nor does a product label establish that treatment is suitable for a particular person without assessment.
When reading a claim about medical use, ask for the generic drug name, formulation, country and date of the product information. A list headed “steroids used in medicine” may mix current therapy with medicines whose approval or availability has changed. The name alone cannot resolve that problem.
Testosterone treatment
The FDA testosterone overview describes treatment for low testosterone associated with medical conditions. The same page reports requested prescribing information changes in June 2026, including changes to an age related limitation and prostate safety information. Older summaries may not reflect those updates.
A patient still needs an assessment of symptoms, relevant tests, the proposed benefit and the particular medicine. A fatigue complaint by itself does not select testosterone treatment. Ask the prescriber what diagnosis is being considered and how the response will be assessed.
Product information differs between jurisdictions. The UK Sustanon 250 record specifies testosterone replacement for confirmed male hypogonadism and also describes supportive testosterone use for masculinising therapy. This is a statement about that UK record, not a claim about every testosterone product worldwide.
Current, historical and research uses
| Claim type | What supports it | What to check next |
|---|---|---|
| Current approved use | Current regulator or product information | Exact formulation and population |
| Historical use | Older records or publications | Changes in status |
| Research use | A study in a defined population | Study design and limits |
| Use outside a label | A clinical decision requiring its own rationale | Why it is proposed and what uncertainties apply |
Oxandrolone illustrates the need to check dates. FDA records describe withdrawal of Oxandrin approval in 2023 and a later determination concerning safety or effectiveness. Old references to an approved American use should not be copied as a current indication. See the FDA withdrawal record for the dated regulatory action.
General health summaries, including MedlinePlus, describe uses involving hormone problems and selected conditions. They are starting points for learning about the class, not a substitute for checking the exact medicine being discussed.
Why treatment studies do not clear nonmedical use
A study of a prescribed formulation in a selected patient group answers a defined question. It cannot establish the safety of an unknown product, a different combination or exposure intended to exceed normal physiology. The clinical literature separates androgen replacement from nonmedical use for appearance or performance.
That distinction matters when someone cites a reassuring trial result. Ask which product was studied, who received it and what outcome was measured. “Testosterone was studied” is not enough to make all anabolic steroid use equivalent.
Monitoring has a purpose
Monitoring is meant to assess treatment response and detect problems; it does not make adverse effects impossible. In 2025 the FDA required testosterone blood pressure warnings after reviewing monitoring studies. Read that update alongside later product information rather than treating a single older notice as the complete current record.
Before treatment, ask which risks are relevant to your health history, how fertility plans affect the choice, and what changes should prompt contact. During treatment, report symptoms and other medicines rather than treating a blood result inside a printed range as proof that treatment is safe.
Questions for the prescriber
- What condition is this medicine intended to treat?
- Which benefits should we look for, and when will we reassess?
- Which product information applies in this country?
- What are the alternatives and the main uncertainties?
- Who should I contact about side effects or a change in plans?
For a broader class overview, visit anabolic steroids. For adverse effects and care decisions, read anabolic steroid health risks. Do not start, stop or change prescribed treatment from this page.